Butyrate enhances Clostridioides difficile sporulation in vitro
Baldassare, M. A.; Bhattacharjee, D.; Coles, J. D.; Nelson, S.; McCollum, C. A.; Seekatz, A. M.
Show abstract
Short chain fatty acids (SCFAs) are products of bacterial fermentation that help maintain important gut functions such as the intestinal barrier, signaling, and immune homeostasis. The main SCFAs acetate, propionate, and butyrate have demonstrated beneficial effects for the host, including importance in combatting infections caused by pathogens such as Clostridioides difficile. Despite the potential role of SCFAs in mitigating C. difficile infection, their direct effect on C. difficile remains unclear. Through a set of in vitro experiments, we investigated how SCFAs influence C. difficile growth, sporulation, and toxin production. Similar to previous studies, we observed that butyrate decreased growth of C. difficile strain 630 in a dose-dependent manner. The presence of butyrate also increased C. difficile sporulation, with minimal increases in toxin production. RNA-Seq analysis validated our experimental results, demonstrating increased expression of sporulation-related genes in conjunction with alternative metabolic and related C. difficile regulatory pathways, such as the carbon catabolite repressor, CcpA. Collectively, these data suggest that butyrate may signal alternative C. difficile metabolic pathways, thus modifying its growth and virulence to persist in the gut environment. IMPORTANCESeveral studies suggest that butyrate may be important in alleviating gut infections, such as reducing inflammation caused by the healthcare-associated Clostridioides difficile. While studies in both animal models and human studies correlate high levels of butyrate with reduced C. difficile burden, the direct impact of butyrate on C. difficile remains unclear. Our study demonstrates that butyrate directly influences C. difficile by increasing its sporulation and modifying its metabolism, potentially using butyrate as a biomarker to shift survival strategies in a changing gut environment. These data point to additional therapeutic approaches to combat C. difficile in a butyrate-directed manner.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- c-di-GMP inhibits early sporulation in Clostridioides difficile 96%
- Dietary xanthan gum alters antibiotic efficacy against the murine gut microbiota and attenuates Clostridioides difficile colonization 95%
- Degradation of the incretin hormone Glucagon-Like Peptide-1 (GLP-1) by Enterococcus faecalis metalloprotease GelE 95%
Similar papers in this journal
- Simulated colonic fluid replicates the in vivo growth capabilities of Citrobacter rodentium cpxRA mutants and uncovers additive effects of Cpx regulated genes on fitness 96%
- c-di-AMP is essential for the virulence of Enterococcus faecalis 96%
- Mcc1229, an Stx2a-amplifying microcin, is produced in vivo and requires CirA for activity 95%
Similar papers in this journal
- C-di-AMP levels modulate Staphylococcus aureus cell wall thickness as well as virulence and contribute to antibiotic resistance and tolerance 94%
- Vibrio cholerae alkalizes its environment via citrate metabolism to inhibit enteric growth 94%
- Gallocin A, an atypical two-peptide bacteriocin with intramolecular disulfide bonds required for activity 94%
Similar papers in this journal
- Protection from lethal Clostridioides difficile infection via intraspecies competition for co-germinant 97%
- Fructose Activates A Stress Response Shared By Methylglyoxal And Hydrogen Peroxide In Streptococcus Mutans 95%
- The gut bacterial community potentiates Clostridioides difficile infection severity 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.